| 名称 | Endomorphin 1 acetate |
| 描述 | Endomorphin 1 acetate is a selective and highly effective μ-opioid receptor agonist with anti-nociceptive and analgesic effects. Endomorphin 1 acetate shows high affinity for kappa3 and can be used to study neurological diseases. |
| 体外活性 | 用各种浓度的 Endomorphin 1 acetate 处理CACO-2细胞。当单独将细胞与 Endomorphin 1 acetate 孵育时,未检测到基底IL-8产生的变化。然而,与单独使用IL-1β处理的细胞相比,在IL-1β存在下用 Endomorphin 1 acetate 处理CACO-2细胞显着增加了IL-8。[1] |
| 体内活性 | 雄性Sprague Dawley大鼠(n = 48)被随机分为四组(n = 12/组):i)对照组,LAD结扎,没有其他干预措施150分钟; ii)IR组:LAD连接30分钟(缺血),并在体内进行120分钟的排列; iii)IPO组,缺血30分钟后,在再灌注前进行了三个LAD夹紧15秒的速率,并在再灌注前进行了15秒。 IV)EM50组:在LAD连接25分钟后静脉内给予 Endomorphin 1 acetate(50μg/kg),随后在体内再生120分钟。
在IR,IPO和 Endomorphin 1 acetate 组中,与对照组相比,LDH和CK-MB活性明显更高。与IR组相比,IPO和 Endomorphin 1 acetate 组的LDH和CK-MB活性显着降低。与对照组相比,在IR组中,IL-6和TNF-α水平显着升高。与IR组相比,IPO和 Endomorphin 1 acetate 组的IL-6和TNF-α水平显着降低。[2] |
| 存储条件 | keep away from moisture,store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 4 mg/mL (5.96 mM), Sonication is recommended. DMSO : 100 mg/mL (149.09 mM), Sonication is recommended.
|
| 关键字 | μ-opioid receptor | OpioidReceptor | Opioid Receptor |
| 相关产品 | Docusate sodium | Naltrexone hydrochloride | Progesterone | SCH 221510 | Amentoflavone | Mirtazapine | Mianserin hydrochloride | (-)-Menthol | Bevenopran | Naloxone HCl Dihydrate | JNJ-20788560 | Trimebutine |
| 相关库 | Bioactive Compound Library | Bioactive Compounds Library Max | Peptide Compound Library | Membrane Protein-targeted Compound Library |